maternal vitamin B, is another independent risk factor for NTD. These observations suggest the enzyme methionine synthase (MS), which is central to folate metabolism and which catalyses the conversion of homocysteine to methionine in a vitamin B,2 dependent reaction, as a target for study. As yet there has been no investigation of the idea that mutations in the MS gene might contribute to NTD susceptibility, but the recent cloning of this gene3 5now makes allele association studies possible. We have investigated DNA samples from British NTD families which include 36 affected subjects, 31 with spina bifida (SB) and five with SB occulta, and Dutch NTD families which include 32 with SB, two with SB occulta, and one with encephalocele.
The Unrelated subjects married in to NTD families (MI) were used as the Dutch control population.
Asp919 and 15 Gly919) but this difference was also not significant X2.DT=2.13, p>0.1.
The TDT is particularly useful since it can be applied separately to mothers of NTD children as well as to their affected offspring.7
In our study we have relatively few families in which grandparents are available for testing. (5) 58.3 (7) 
